Evotec and Sanofi partner on beta cell therapy for diabetes

01 Feb 2023

Evotec AG and Sanofi agreed to develop a beta cell replacement therapy for diabetes.

Pharmaceuticals
Biotechnology
- Drug Discovery Technologies
- Gene Therapy, Cell Therapy
- Large Molecule

Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Evotec and Sanofi partner on beta cell therapy for diabetes

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice